Literature DB >> 24286933

Characterization of knee osteoarthritis in Latin America. A comparative analysis of clinical and health care utilization in Argentina, Brazil, and Mexico.

Rubén Burgos-Vargas1, Mario H Cardiel2, Adalberto Loyola-Sánchez3, Mirhelen Mendes De Abreu4, Bernardo A Pons-Estel5, Michel Rossignol6, Bernard Avouac7, Marcos Bosi Ferraz8, Hafid Halhol9.   

Abstract

BACKGROUND: The burden of knee osteoarthritis (OA) in Latin America is unknown.
OBJECTIVE: To determine the demographic, clinical, and therapeutic characteristics of patients with OA in Argentina, Brazil, and Mexico.
MATERIAL AND METHODS: This is an observational, cross-sectional study of patients with symptomatic knee OA referred from first care medical centers to Rheumatology departments.
RESULTS: We included 1210 patients (Argentina 398, Brazil 402, Mexico 410; mean age 61.8 [12] years; 80.8% females). Knee OA pain lasted for 69 months; the duration and severity of the last episode were 190 days and (SD 5.2 [3.3]; 74% had functional limitations, but very few patients lost their job because of knee OA. Around 71% had taken medications, but 63% relied on their own pocket to afford knee OA cost. Most demographic and clinical variables differed across countries, particularly the level of pain, disability, treatment, and access to care. The variable country of origin influenced the level of pain, disability, and NSAIDs use in logistic regression models; age, pain, treatment, and health care access influenced at least 2 of the models.
CONCLUSIONS: The burden of knee OA in Latin American depends on demographic, clinical, and therapeutic variables. The role of such variables differs across countries. The level of certain variables is significantly influenced by country of origin and health care system.
Copyright © 2013 Elsevier España, S.L. All rights reserved.

Entities:  

Keywords:  Health care needs and demand; Knee; Necesidades y demanda de atención de salud; Osteoarthritis; Osteoartritis; Rodilla

Mesh:

Year:  2013        PMID: 24286933     DOI: 10.1016/j.reuma.2013.07.013

Source DB:  PubMed          Journal:  Reumatol Clin        ISSN: 1699-258X


  6 in total

1.  Mexican rheumatology: where do we stand?

Authors:  Carlos Pineda; Hugo Sandoval; Antonio Fraga-Mouret
Journal:  Rheumatol Int       Date:  2018-11-12       Impact factor: 2.631

2.  Long-Term Effectiveness of Polymerized-Type I Collagen Intra-Articular Injections in Patients with Symptomatic Knee Osteoarthritis: Clinical and Radiographic Evaluation in a Cohort Study.

Authors:  Adrián Borja-Flores; Salvador I Macías-Hernández; Gabriela Hernández-Molina; Andric Perez-Ortiz; Eloy Reyes-Martínez; José Belzazar-Castillo de la Torre; Laura Ávila-Jiménez; María Cristina Vázquez-Bello; Marco Antonio León-Mazón; Janette Furuzawa-Carballeda; Gonzalo Torres-Villalobos; Fernanda Romero-Hernández; Cidronio Albavera-Hernández; Jesús Pérez-Correa; Hilda A Castro-Rocha
Journal:  Adv Orthop       Date:  2020-07-22

Review 3.  Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies.

Authors:  Feng Xie; Bruno Kovic; Xuejing Jin; Xiaoning He; Mengxiao Wang; Camila Silvestre
Journal:  Pharmacoeconomics       Date:  2016-11       Impact factor: 4.981

4.  Medical Expenditure for Chronic Diseases in Mexico: The Case of Selected Diagnoses Treated by the Largest Care Providers.

Authors:  Alejandro Figueroa-Lara; Miguel Angel Gonzalez-Block; Jose Alarcon-Irigoyen
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

Review 5.  Assessing the burden of osteoarthritis in Latin America: a rapid evidence assessment.

Authors:  Daniel Ciampi de Andrade; Diego Saaibi; Nicolas Sarría; Nora Vainstein; Leslie Cano Ruiz; Rolando Espinosa
Journal:  Clin Rheumatol       Date:  2022-01-29       Impact factor: 3.650

Review 6.  Implementation of Best-Evidence Osteoarthritis Care: Perspectives on Challenges for, and Opportunities From, Low and Middle-Income Countries.

Authors:  Jillian P Eyles; Saurab Sharma; Rosa Weiss Telles; Mosedi Namane; David J Hunter; Jocelyn L Bowden
Journal:  Front Rehabil Sci       Date:  2022-01-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.